Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Current Assets (2024 - 2026)

Carlsmed filings provide 2 years of Current Assets readings, the most recent being $126.7 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 156.68% to $126.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $126.7 million, a 156.68% increase, with the full-year FY2025 number at $126.7 million, up 156.68% from a year prior.
  • Current Assets hit $126.7 million in Q4 2025 for Carlsmed, down from $131.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $131.5 million in Q3 2025 to a low of $46.2 million in Q2 2025.